Stay updated with breaking news from John Nuss. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
05.06.2024 - VTX3232 demonstrated improvements in body weight, systemic inflammatory biomarkers and cardiometabolic parameters in diet-induced obesity (DIO) mice Additive effects were observed for VTX3232 in combination with the GLP-1 receptor agonist ... Seite 1
Ventyx Biosciences, Inc. (NASDAQ:VTYX – Get Free Report) rose 5% during mid-day trading on Tuesday . The company traded as high as $8.75 and last traded at $8.44. Approximately 937,127 shares were traded during trading, a decline of 82% from the average daily volume of 5,087,228 shares. The stock had previously closed at $8.04. Analyst […]
Ventyx Biosciences (NASDAQ:VTYX – Get Free Report) issued its quarterly earnings data on Tuesday. The company reported ($0.79) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.87) by $0.08, Briefing.com reports. During the same period in the prior year, the company earned ($0.62) earnings per share. Ventyx Biosciences Stock Performance Shares of […]
Ventyx Biosciences (NASDAQ:VTYX – Get Free Report) posted its quarterly earnings data on Tuesday. The company reported ($0.79) EPS for the quarter, beating analysts’ consensus estimates of ($0.87) by $0.08, Briefing.com reports. During the same period in the previous year, the firm earned ($0.62) earnings per share. Ventyx Biosciences Price Performance Shares of NASDAQ VTYX […]
Connor Clark & Lunn Investment Management Ltd. increased its holdings in Ventyx Biosciences, Inc. (NASDAQ:VTYX – Free Report) by 139.5% in the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 63,944 shares of the company’s stock after purchasing an additional 37,240 shares during the period. Connor Clark […]